+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLPL GLPL

Goldline Pharmaceutical Share Price

₹29.00 +0.23 (0.8%)

18 Nov, 2026 3:03 PM (IST)

Goldline Pharmaceutical live price: ₹29.00. It opened at ₹29 vs previous close ₹29; intraday high/low: ₹29/₹29. The 50 DMA stands at ₹33.50.

Goldline Pharmaceutical Performance

  • Today's Low
  • ₹29
  • Today's High
  • ₹29
  • 52 Week Low
  • ₹28
  • 52 Week High
  • ₹60
  • Open Price₹29
  • Previous Close₹29
  • Volume6,000
  • 50 DMA₹33.50
  • 100 DMA₹37.90
  • 200 DMA-

Goldline Pharmaceutical Chart

Investment Returns

  • Over 1 Month -10.71%
  • Over 3 Month -27.66%

Smart Investing Starts Here Start SIP with Goldline Pharmaceutical for Steady Growth!

Invest Now

Goldline Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 28
  • P/B Ratio
  • 2.1
  • Average True Range
  • 1.5
  • EPS
  • 4.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.1
  • RSI
  • 39.31
  • MFI
  • 45.74

Latest Stock News Updates

Goldline Pharmaceutical Ltd - 544759 - Submission Of Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('SEBI Listing Regulations') For The Half Year Ended 30Th September 2026.

Submission of statement of deviation and variation of the half year ended 30th september 2026

Goldline Pharmaceutical Ltd - 544759 - Declaration Of Un-Audited Standalone Financial Results Of The Company For The Half Year Ended September 30, 2026

Declaration of Un-audited Standalone Financial Results of the company for the half year ended September 30, 2026

Goldline Pharmaceutical Ltd - 544759 - Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th November, 2026 Pursuant To Reg 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Outcome of Board Meeting dated 14th November, 2026 pursuant to Reg 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 & Submission of Un-audited Standalone Financial Results of the Company for the half year ended September 30, 2026.

Goldline Pharmaceutical Financials

Goldline Pharmaceutical Technicals

EMA & SMA

Current Price
₹29.00
+ 0.23 (0.8%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 0
  • 20 Day
  • ₹30.90
  • 50 Day
  • ₹33.50
  • 100 Day
  • ₹37.90
  • 200 Day
  • -

Resistance and Support

29 Pivot Speed
  • R3 31.00
  • R2 30.50
  • R1 29.70
  • S1 28.30
  • S2 27.90
  • S3 27.00

Goldline Pharmaceutical Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Half Yearly Results
2026-06-09 Audited Results

Goldline Pharmaceutical Shareholding Pattern

59.54%
40.05%
0.31%
0.09%

About Goldline Pharmaceutical

Goldline Pharmaceutical are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” View More
  • NSE Symbol
  • GLPL
  • BSE Symbol
  • 544759
  • ISIN
  • INE1CLW01015

Similar Stocks to Goldline Pharmaceutical

Goldline Pharmaceutical FAQs

Goldline Pharmaceutical share price is ₹29 As on 18 November, 2026 | 15:02

The Market Cap of Goldline Pharmaceutical is ₹27.8 Cr As on 18 November, 2026 | 15:02

The P/E ratio of Goldline Pharmaceutical is 6.8 As on 18 November, 2026 | 15:02

The PB ratio of Goldline Pharmaceutical is 2.1 As on 18 November, 2026 | 15:02

The 52 week High & Low of Goldline Pharmaceutical is ₹60/₹28.1 respectively As on 18 November, 2026 | 15:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23